Clinical trial
Safety and Effects of Implanted (Autologous) Skeletal Myoblasts (MyoCell) Using…
NCT00375817 · Bioheart, Inc., Industry · Unknown status
Key facts
| NCT number | NCT00375817 |
|---|---|
| Title | Safety and Effects of Implanted (Autologous) Skeletal Myoblasts (MyoCell) Using an Injection Catheter = SEISMIC Trial |
| Official title | A Phase II, Open-Label, Randomized, Multicenter Study to Assess the Safety and Cardiovascular Effects of MyoCell Implantation by a Catheter Delivery System in Congestive Heart Failure Patients Post Myocardial Infarction(s) |
| Lead sponsor | Bioheart, Inc., Industry |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Myocardial Infarction, Heart Failure, Congestive |
| Intervention type | Procedure |
| Interventions | Myoblasts injection with MyoCath catheter |
| Enrollment | 40 |
| Start date | Nov 1, 2005 |
| Completion | Jan 1, 2008 |
| First posted | Sep 13, 2006 |
| Last update posted | Oct 12, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: